News
-
First look at ovarian cancer audit feasibility pilot data
The ovarian cancer audit feasibility pilot findings reveals big differences in the number of diagnoses across England and significant variation in early detection. -
Talcum Powder and ovarian cancer: What’s the story?
A new study published in the medical journal JAMA has found no statistically significant relationship between talc use and the development of ovarian cancer. -
Scotland follows England, Wales and Northern Ireland in making olaparib available to all women with hereditary ovarian cancer
Maintenance treatment olaparib is now available to women diagnosed with BRCA-mutated ovarian cancer through the Scottish Medicine Consortium. -
"We had lots of laughs and bonded with each other as we walked through the busy roads in London"
On October 18th, Natwest walked the London Marathon Route to raise funds for Ovarian Cancer Action. One member of the team, Adam, shares his experience.
-
One Cancer Voice: A manifesto for people living with cancer
Ovarian Cancer Action is one of 28 cancer charities launching a joint manifesto on behalf of cancer patients across the UK today
-
Ovarian Cancer Action launched a campaign for the next generation
The Ovarian Cancer Action campaign that focuses on the next generation, ensuring that with investment into research and greater awareness, the future will be different.
-
OCA invests £900,000 in new research to create better ovarian cancer treatments
Ovarian Cancer Action awards £900,000 to two brand new research projects whose goal is to create new and better treatments for ovarian cancer patients. -
A new treatment option for women with relapsed ovarian cancer
There was positive news today for women with relapsed ovarian cancer, with the announcement that a new treatment, rucaparib (also known as Rubraca), will now be available on the NHS.
-
Beyoncé’s father reveals family’s BRCA link following his breast cancer diagnosis
This week, Matthew Knowles – father of singers Beyoncé and Solange Knowles – shone a different light on both breast cancer and BRCA when he revealed he was recently diagnosed with breast cancer and carries a mutation in his BRCA2 gene.
-
Personalised treatment becomes a reality for women with hereditary ovarian cancer
In the news today, PARP inhibitor olapoarib is now available to women with newly diagnosed BRCA-mutated ovarian, fallopian and peritoneal cancer following first-line chemotherapy.
-
Healthcare professionals call for tighter restrictions on at-home genetic testing kits
Senior doctors have called for stricter regulations around consumer genetic testing kits such as 23andMe and AncestryDNA.
-
New immunotherapy trial for patients with advanced cancer
Funding has been granted to a study where patients with advanced cancer will test a new therapy called bermekibab, aimed at reducing their symptoms and improving their quality of life.
-
Ovarian Cancer Action awarded ‘Charity, Professional or Patient Association of the Year’ at The Communiqué Awards
Ovarian Cancer Action has been awarded ‘Charity, Professional or Patient Association of the Year’ at The Communiqué Awards. -
Obesity as a risk factor for ovarian cancer
Around 7% of ovarian cancer cases are caused by being overweight or obese and 1% of cases are caused by smoking. However, whilst these figures highlight that it is important to lead a healthy lifestyle, they also show that the majority of ovarian cancer cases are unrelated to obesity.
-
Is there a new ovarian cancer screening tool on the horizon?
In the news today, new research from Uppsala University in Sweden has been reported as a potential new blood test to detect ovarian cancer.
-
166,000 people in UK population unaware they have Lynch syndrome
In the week that saw the passing of Dr Henry Lynch, a scientist renowned for his work on hereditary cancer, NHS Wales will begin offering genetic testing for Lynch syndrome to all bowel cancer patients. We reflect on the significance of Dr Lynch’s work and how his legacy is continuing to save lives.
-
Politicians in England, Wales and Scotland unite behind our World Ovarian Cancer Day campaign
Ovarian cancer is a complicated disease – it’s difficult to diagnose and challenging to treat – and it doesn’t always get the attention it deserves. This year we were delighted to see politicians in England, Wales and Scotland helping put a spotlight on the disease, uniting behind our World Ovarian Cancer Day campaign for earlier diagnosis.
-
The new NHS 10-year plan: What does it mean for ovarian cancer?
The NHS Long-Term Plan was published in early 2019. We take a look at some of the key ambitions and what they mean for ovarian cancer.
-
New class of drugs could stop ovarian cancer cell growth
Researchers from The University of Manchester hope their findings could lead to new targeted treatment for ovarian cancer
-
New cancer figures released for Northern Ireland
We take a look at how ovarian cancer diagnosis and survival in Northern Ireland has changed over the last few decades